Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Wada N, Irie H, Hidaka T, Hashimoto A, Aiba S.

Front Oncol. 2018 Nov 19;8:530. doi: 10.3389/fonc.2018.00530. eCollection 2018.

2.

Keratoacanthoma Centrifugum Marginatum with Spontaneous Regression and Its Possible Differential Diagnosis.

Amagai R, Fujimura T, Kambayashi Y, Furudate S, Sato Y, Tanita K, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Oct 24;11(3):671-675. doi: 10.1159/000493089. eCollection 2018 Sep-Dec.

3.

Modification of cellular and humoral immunity by somatically reverted T cells in X-linked lymphoproliferative syndrome type 1.

Hoshino A, Yang X, Tanita K, Yoshida K, Ono T, Nishida N, Okuno Y, Kanzaki T, Goi K, Fujino H, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H.

J Allergy Clin Immunol. 2018 Oct 11. pii: S0091-6749(18)31288-0. doi: 10.1016/j.jaci.2018.07.044. [Epub ahead of print] No abstract available.

PMID:
30342818
4.

Gain-of-function IKBKB mutation causes human combined immune deficiency.

Cardinez C, Miraghazadeh B, Tanita K, da Silva E, Hoshino A, Okada S, Chand R, Asano T, Tsumura M, Yoshida K, Ohnishi H, Kato Z, Yamazaki M, Okuno Y, Miyano S, Kojima S, Ogawa S, Andrews TD, Field MA, Burgio G, Morio T, Vinuesa CG, Kanegane H, Cook MC.

J Exp Med. 2018 Nov 5;215(11):2715-2724. doi: 10.1084/jem.20180639. Epub 2018 Oct 18.

PMID:
30337470
5.

Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs.

Tanita K, Fujimura T, Sato Y, Lyu C, Aiba S.

Exp Dermatol. 2018 Nov;27(11):1268-1272. doi: 10.1111/exd.13779. Epub 2018 Oct 9.

PMID:
30192415
6.

High frequencies of asymptomatic Epstein-Barr virus viremia in affected and unaffected individuals with CTLA4 mutations.

Hoshino A, Tanita K, Kanda K, Imadome KI, Shikama Y, Yasumi T, Imai K, Takagi M, Morio T, Kanegane H.

Clin Immunol. 2018 Oct;195:45-48. doi: 10.1016/j.clim.2018.07.012. Epub 2018 Jul 24.

PMID:
30048690
7.

Widely Spread Unilateral Inflammatory Linear Verrucous Epidermal Nevus (ILVEN).

Tanita K, Fujimura T, Sato Y, Lyu C, Aiba S.

Case Rep Dermatol. 2018 Jun 14;10(2):170-175. doi: 10.1159/000489876. eCollection 2018 May-Aug.

8.

Two cases of dabrafenib and trametinib therapy-failed advanced melanoma successfully controlled by nivolumab monotherapy.

Sato Y, Fujimura T, Kambayashi Y, Tanita K, Tono H, Hashimoto A, Aiba S.

J Dermatol. 2018 Sep;45(9):1105-1108. doi: 10.1111/1346-8138.14508. Epub 2018 Jun 20.

PMID:
29923635
9.

Droplet Digital PCR-Based Chimerism Analysis for Primary Immunodeficiency Diseases.

Okano T, Tsujita Y, Kanegane H, Mitsui-Sekinaka K, Tanita K, Miyamoto S, Yeh TW, Yamashita M, Terada N, Ogura Y, Takagi M, Imai K, Nonoyama S, Morio T.

J Clin Immunol. 2018 Apr;38(3):300-306. doi: 10.1007/s10875-018-0497-8. Epub 2018 Apr 18.

PMID:
29671114
10.

Three patients with advanced cutaneous angiosarcoma treated with eribulin: investigation of serum soluble CD163 and chemokine (C-X-C motif) ligand 10 as possible biomarkers predicting the biological behaviour of angiosarcoma.

Fujimura T, Sato Y, Kambayashi Y, Tanita K, Tsukada A, Terui H, Hashimoto A, Aiba S.

Br J Dermatol. 2018 Dec;179(6):1392-1395. doi: 10.1111/bjd.16676. Epub 2018 Jul 5.

PMID:
29663331
11.

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study.

Fujimura T, Sato Y, Tanita K, Kambayashi Y, Otsuka A, Fujisawa Y, Yoshino K, Matsushita S, Funakoshi T, Hata H, Yamamoto Y, Uchi H, Nonomura Y, Tanaka R, Aoki M, Imafuku K, Okuhira H, Furudate S, Hidaka T, Aiba S.

Oncotarget. 2018 Feb 15;9(21):15542-15551. doi: 10.18632/oncotarget.24509. eCollection 2018 Mar 20.

12.

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab.

Tanita K, Fujimura T, Kambayashi Y, Tsukada A, Sato Y, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Feb 15;11(1):114-118. doi: 10.1159/000487127. eCollection 2018 Jan-Apr.

13.

Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy.

Fujimura T, Tanita K, Sato Y, Kambayashi Y, Furudate S, Tsukada A, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jan 16;11(1):29-32. doi: 10.1159/000486278. eCollection 2018 Jan-Apr.

14.

Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod.

Fujimura T, Kambayashi Y, Sato Y, Tanita K, Furudate S, Tsukada A, Tono H, Hashimoto A, Aiba S.

Case Rep Oncol. 2018 Jan 4;11(1):1-5. doi: 10.1159/000485612. eCollection 2018 Jan-Apr.

15.

HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.

Fujimura T, Kambayashi Y, Tanita K, Sato Y, Hidaka T, Otsuka A, Tanaka H, Furudate S, Hashimoto A, Aiba S.

J Dermatol. 2018 Jun;45(6):735-737. doi: 10.1111/1346-8138.14273. Epub 2018 Feb 27.

PMID:
29488243
16.

The Expression of Matrix Metalloproteinases in Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL)-expressing Cancer of Apocrine Origin.

Kambayashi Y, Fujimura T, Furudate S, Lyu C, Hidaka T, Kakizaki A, Sato Y, Tanita K, Aiba S.

Anticancer Res. 2018 Jan;38(1):113-120.

PMID:
29277763
17.

Successful treatment of relapsed folliculotropic mycosis fungoides with mogamulizumab followed by intensity-modulated radiotherapy.

Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.

J Dermatol. 2018 Apr;45(4):e84-e85. doi: 10.1111/1346-8138.14111. Epub 2017 Oct 25. No abstract available.

PMID:
29068082
18.

Successful control of phototherapy-resistant lymphomatoid papulosis with oral bexarotene.

Fujimura T, Furudate S, Tanita K, Sato Y, Kambayashi Y, Hidaka T, Aiba S.

J Dermatol. 2018 Feb;45(2):e37-e38. doi: 10.1111/1346-8138.14095. Epub 2017 Oct 3. No abstract available.

PMID:
28971510
19.

Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages.

Fujimura T, Kakizaki A, Kambayashi Y, Sato Y, Tanita K, Lyu C, Furudate S, Aiba S.

Exp Dermatol. 2018 Jan;27(1):64-70. doi: 10.1111/exd.13417. Epub 2017 Oct 26.

PMID:
28833504
20.

Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.

Petersheim D, Massaad MJ, Lee S, Scarselli A, Cancrini C, Moriya K, Sasahara Y, Lankester AC, Dorsey M, Di Giovanni D, Bezrodnik L, Ohnishi H, Nishikomori R, Tanita K, Kanegane H, Morio T, Gelfand EW, Jain A, Secord E, Picard C, Casanova JL, Albert MH, Torgerson TR, Geha RS.

J Allergy Clin Immunol. 2018 Mar;141(3):1060-1073.e3. doi: 10.1016/j.jaci.2017.05.030. Epub 2017 Jun 17.

PMID:
28629746
21.

The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.

Fujimura T, Kakizaki A, Sato Y, Tanita K, Furudate S, Aiba S.

Anticancer Res. 2017 Jun;37(6):2867-2873.

PMID:
28551623
22.

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy.

Tanita K, Fujimura T, Sato Y, Hidaka T, Furudate S, Kambayashi Y, Tsukada A, Hashimoto A, Aiba S.

Case Rep Oncol. 2017 Apr 6;10(1):328-332. doi: 10.1159/000468981. eCollection 2017 Jan-Apr.

23.

Keratoacanthoma, palmoplantar keratoderma developing in an advanced melanoma patient treated with vemurafenib regressed by blockade of mitogen-activated protein kinase kinase signaling.

Furudate S, Fujimura T, Kambayashi Y, Hidaka T, Sato Y, Tanita K, Hashimoto A, Aiba S.

J Dermatol. 2017 Sep;44(9):e226-e227. doi: 10.1111/1346-8138.13898. Epub 2017 Apr 25. No abstract available.

PMID:
28439948
24.

Recurrent Multiple Squamous Cell Carcinomas on the Scalp in a Patient with Juvenile Dermatomyositis.

Sato Y, Fujimura T, Kambayashi Y, Tsukada A, Hidaka T, Tanita K, Haga T, Hashimoto A, Aiba S.

Case Rep Oncol. 2017 Jan 20;10(1):106-111. doi: 10.1159/000456001. eCollection 2017 Jan-Apr.

25.

Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.

Furudate S, Fujimura T, Tsukada A, Sato Y, Hidaka T, Tanita K, Kambayashi Y, Haga T, Hashimoto A, Aiba S.

Case Rep Oncol. 2017 Jan 16;10(1):52-56. doi: 10.1159/000455091. eCollection 2017 Jan-Apr.

26.

Successful treatment of multiple in-transit melanomas on the leg with intensity-modulated radiotherapy and immune checkpoint inhibitors: Report of two cases.

Fujimura T, Kambayashi Y, Furudate S, Hidaka T, Sato Y, Tanita K, Tono H, Tsukada A, Hashimoto A, Aiba S.

J Dermatol. 2017 May;44(5):592-595. doi: 10.1111/1346-8138.13707. Epub 2016 Dec 3.

PMID:
27914096
27.

Periostin in the Cancer Stroma of Mycosis Fungoides Palmaris et Plantaris: A Case Report and Immunohistochemical Study.

Tanita K, Fujimura T, Kakizaki A, Furudate S, Mizuashi M, Watabe A, Aiba S.

Case Rep Dermatol. 2016 Feb 6;8(1):31-5. doi: 10.1159/000444162. eCollection 2016 Jan-Apr.

28.

Psoriasiform Drug Eruption Caused by Abatacept: Immunohistochemical Investigation of STAT Signaling.

Tanita K, Fujimura T, Kakizaki A, Furudate S, Kusakari Y, Aiba S.

Case Rep Dermatol. 2015 Jul 24;7(2):166-70. doi: 10.1159/000437415. eCollection 2015 May-Aug.

29.

Acquired Idiopathic Generalized Anhidrosis: An Immunohistopathological Investigation of Peri-glands Infiltrated with Immunoreactive Cells.

Iwama E, Fujimura T, Tanita K, Ishibashi M, Watabe A, Aiba S.

Acta Derm Venereol. 2015 Jul;95(6):743-4. doi: 10.2340/00015555-2034. No abstract available.

30.

[Public health nursing activities based on the CMI(Cornell Medical Index)].

Mitsumori N, Tanita K.

Hokenfu Zasshi. 1977 Apr;33(4):243-50. Japanese. No abstract available.

PMID:
584873

Supplemental Content

Loading ...
Support Center